Skechers U.S.A., Inc. (SKX): What’s the Story?

Skechers U.S.A., Inc. (SKX) is an interesting player in the Consumer Goods space, with a focus on Textile – Apparel Footwear & Accessories. The stock has been active on the tape, currently trading at $40.00, down from yesterday’s close by -2.58%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Skechers U.S.A., Inc. (SKX) currently trades with a market capitalization of $5.89 Billion. That value represents a market adjusting for revenues that have been growing by 26.99 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $153.3 Million over the past twelve months. Generally speaking, earnings are expected to fall in coming quarters. Analysts are forecasting earnings of $0.74 on a per share basis this quarter. Perhaps, that suggests something about why 0.89% of the outstanding share supply is held by institutional investors.



Technical Analysis

It’s important to check the technicals to get a sense of how SKX has been acting. Looking at the stock’s movement on the chart, Skechers U.S.A., Inc. recorded a 52-week high of $42.73. It is now trading 2.73% off that level. The stock is trading $38.47 its 50-day moving average by -1.53%. The stock carved out a 52-week low down at $22.64.

In recent action, Skechers U.S.A., Inc. (SKX) has made a move of +3.76% over the past month, which has come on weak relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 12.51, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 4.75% with $132.19 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of SKX.

SHARE
Previous articleDigging Up the Facts on Infinera Corporation (INFN)
Next articleChecking the Overall Picture for AVEO Pharmaceuticals, Inc. (AVEO)